An Infant presents with hepatomegaly, hypoglycemia, hyperlipidemia and acidosis. Most probable underlying diagnosis is:
**Core Concept**
The infant's presentation of hepatomegaly, hypoglycemia, hyperlipidemia, and acidosis suggests a disorder of fatty acid oxidation, specifically a deficiency in the enzyme medium-chain acyl-CoA dehydrogenase (MCAD). This enzyme plays a crucial role in the breakdown of fatty acids for energy production.
**Why the Correct Answer is Right**
MCAD deficiency is a genetic disorder that leads to impaired fatty acid oxidation, resulting in the accumulation of toxic intermediates. The accumulation of these intermediates causes liver dysfunction, leading to hepatomegaly. The inability to utilize fatty acids for energy production leads to increased gluconeogenesis, resulting in hypoglycemia. Additionally, the accumulation of fatty acids and their derivatives contributes to hyperlipidemia and metabolic acidosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the clinical presentation described, as glycogen storage diseases typically present with hypoglycemia and hepatomegaly but do not typically cause hyperlipidemia and acidosis.
**Option B:** While Pompe disease is a glycogen storage disorder that can cause hepatomegaly, it does not typically present with hyperlipidemia and acidosis.
**Option C:** This option is not relevant to the clinical presentation described, as disorders of mitochondrial function can present with a wide range of symptoms, but the specific combination of hepatomegaly, hypoglycemia, hyperlipidemia, and acidosis is more suggestive of MCAD deficiency.
**Clinical Pearl / High-Yield Fact**
MCAD deficiency is a treatable disorder, and early diagnosis and treatment can prevent long-term complications. It is essential to consider this diagnosis in infants presenting with hepatomegaly, hypoglycemia, hyperlipidemia, and acidosis.
**Correct Answer: C. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency**